Skip to content

13F-HR filed by Vivo Capital, LLC

Vivo Capital, LLC filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-13, with 5 holding rows worth $878,828,000.

Accession
0001213900-19-023217
Filed
2019-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2019

A holdings report, 49 entries on the cover page, a total value of $878,828,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $878,828,000 with VALUE read as thousands by filing date, 13F file number 028-17467. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Aclaris Therapeutics, Inc.000Common00461U10582,834,668$600,219,000thousands by filing date
Ascendis Pharma A/S000000ADR04351P1012,552,237$207,939,000thousands by filing date
SPOTIFY TECHNOLOGY SA000000SHSSHS9,610,156$48,250,000thousands by filing date
NATURA &CO HOLDING-ADR000000ADSADS2,805,035$22,411,000thousands by filing date
Soleno Therapeutics, Inc. - Warrant00Warrant834203135188,772$9,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001213900-19-023217this filing2019-11-13acceptance time not in the bulk data set